RUN vs SABSW · P/E 6.0, rev $1.59B vs P/E 0.0
Sunrun Inc (RUN) versus SAB Biotherapeutics Inc (SABSW) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
Latest reported RUN revenue for 2026-06-30 was $1.59B. Net income was $282.8M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
SABSW does not have a complete income-statement cache yet.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. SABSW currently screens at market cap $0 and trailing P/E 0.0.
Not investment advice. Open the RUN and SABSW stock pages for the full models.
Not investment advice.